Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Manasson

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinical Rheumatology|November 16, 2017
Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-upHelga Raquel Garcia Ferrer, Alexander Azan, Isa Iraheta, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|November 13, 2008
Impact of ambulatory computerized physician order entry on clinicians' timeJonathan P Ungar, Jonathan Pasey Ungar, Tejal K Gandhi, et al.
Neurology|February 20, 2025
Preclinical Pharmacology of S-1117, a Novel Engineered Fc-fused IgG Cleaving Enzyme, for Chronic Treatment of Autoantibody-mediated Diseases (P4-14.018)Ivan Mascanfroni, Julia Manasson, Alex Pellerin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 6, 2018
Microbiota-Dependent Involvement of Th17 Cells in Murine Models of Inflammatory ArthritisHeather Evans-Marin, Rebecca Rogier, Sergei B Koralov, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 27, 2017
Gut Microbiota Perturbations in Reactive Arthritis and Postinfectious SpondyloarthritisJulia Manasson, Nan Shen, Helga R Garcia Ferrer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2014
Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel diseaseJose U Scher, Carles Ubeda, Alejandro Artacho, et al.
Annals of the Rheumatic Diseases|January 4, 2023
Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skinAlba Boix-Amorós, Michelle H Badri, Julia Manasson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2026
Polypharmacology of S-1117, an Fc-fused IgG-selective degrading enzyme, for chronic treatment of autoantibody-mediated diseasesLiliana M Sanmarco, Alex Pellerin, Tobias Green, et al.
Microbiome|June 25, 2017
Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritisRebecca Rogier, Thomas H A Ederveen, Jos Boekhorst, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 14, 2020
The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid ArthritisAlejandro Artacho, Sandrine Isaac, Renuka Nayak, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinical Rheumatology|November 16, 2017
Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-upHelga Raquel Garcia Ferrer, Alexander Azan, Isa Iraheta, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|November 13, 2008
Impact of ambulatory computerized physician order entry on clinicians' timeJonathan P Ungar, Jonathan Pasey Ungar, Tejal K Gandhi, et al.
Neurology|February 20, 2025
Preclinical Pharmacology of S-1117, a Novel Engineered Fc-fused IgG Cleaving Enzyme, for Chronic Treatment of Autoantibody-mediated Diseases (P4-14.018)Ivan Mascanfroni, Julia Manasson, Alex Pellerin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 6, 2018
Microbiota-Dependent Involvement of Th17 Cells in Murine Models of Inflammatory ArthritisHeather Evans-Marin, Rebecca Rogier, Sergei B Koralov, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 27, 2017
Gut Microbiota Perturbations in Reactive Arthritis and Postinfectious SpondyloarthritisJulia Manasson, Nan Shen, Helga R Garcia Ferrer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 17, 2014
Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel diseaseJose U Scher, Carles Ubeda, Alejandro Artacho, et al.
Annals of the Rheumatic Diseases|January 4, 2023
Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skinAlba Boix-Amorós, Michelle H Badri, Julia Manasson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2026
Polypharmacology of S-1117, an Fc-fused IgG-selective degrading enzyme, for chronic treatment of autoantibody-mediated diseasesLiliana M Sanmarco, Alex Pellerin, Tobias Green, et al.
Microbiome|June 25, 2017
Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritisRebecca Rogier, Thomas H A Ederveen, Jos Boekhorst, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 14, 2020
The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New-Onset Rheumatoid ArthritisAlejandro Artacho, Sandrine Isaac, Renuka Nayak, et al.
Pageof 3